HFA Premium Access

Riociguat - new therapeutic option in the management of cardiac amyloidosis

Congress Session

About the speaker

Doctor Franz Duca

Medical University of Vienna, Vienna (Austria)
0 follower

8 more presentations in this session

Cardiac magnetic resonance derived extracellular volume fraction estimates myocardial fibrosis in patients with cardiomyopathy without inflammation but not in presence of significant inflammation

Speaker: Doctor P. Lurz (Leipzig, DE)

Thumbnail

Survival after first heart failure hospitalization in slovenia between 2004 and 2012

Speaker: Doctor D. Omersa (Ljubljana, SI)

Thumbnail

Quantitative contributor of comorbidities in HF patients according to HF phenotypes.

Speaker: Doctor C. Di Nora (Udine, IT)

Thumbnail

Chagas' cardiomyopathy mortality in the 21st century: seven years prospective follow up

Thumbnail

Clinical characteristics and long term outcome of peripartum cardiomyopathy in a resource limited setting.

Speaker: Doctor E. Gambahaya (Harare, ZW)

Thumbnail

Access the full session

Moderated Poster Session 2 - Cardiomyopathy

Speakers: Doctor F. Duca, Doctor P. Lurz, Doctor D. Omersa, Doctor C. Di Nora, Doctor E. Gambahaya
Thumbnail

About the event

Image

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk